Faculty

Nagarajan Kannan, Ph.D., M.S.

Clinical Studies

Living Breast Organoid Biobank for Translational Research Rochester, Minn., Jacksonville, Fla.
Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem cell research. Subjects in the Biobank will provide samples of excess breast tissue, complete a health questionnaire, and allow access to medical records now and in the future. The Biobank serves as a library for researchers; instead of having to look for volunteers for each new project, researchers can use samples from the Biobank as well as share information already collected.
Production of Fallopian Tube Organoids for Translational Research Rochester, Minn.
The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will culminate in launching chemoprevention trials at Mayo.

Evaluating the Regenerative Potential of Human Salivary Cells Rochester, Minn.
The purpose of this study is to obtain excess non-malignant submandibular salivary tissues and clinical data from patients undergoing head & neck surgery, and conduct research activities at Mayo Clinic.

Living Breast Organoid Biobank for Translational Research Scottsdale/Phoenix, Ariz.
Researchers at Mayo Clinic are developing a Biobank of adult stem cell-rich breast organoids, a new research resource to facilitate normal and cancer stem cell research. Subjects in the Biobank will provide samples of excess breast tissue, complete a health questionnaire, and allow access to medical records now and in the future. The Biobank serves as a library for researchers; instead of having to look for volunteers for each new project, researchers can use samples from the Biobank as well as share information already collected.
Production of Fallopian Tube Organoids for Translational Research Jacksonville, Fla.
The aim of this study is to develop and bank organoids for collaborative use in subsequent etiological, biomarker and chemoprevention studies that will culminate in launching chemoprevention trials at Mayo.